GLP-1 Agonist Therapy Attenuates Circulating Gut-Derived Trimethylamine N-Oxide (TMAO) and Improves Cardiac Function and Exercise Performance in Cardiometabolic HFpEF

AHA Scientific Sessions 2025 Abstract

The paper

Elbatreek M, Shah S, Tang WH et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4359480

doi.org/10.1161/circ.152.suppl_3.4359480